- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alembic Pharmaceuticals Limited — Updates, 05-02-2026: Press Release
05-02-2026 | 02:08 pm
05-02-2026 | 02:08 pm
Alembic Pharma's Q3FY26 revenue jumped 11% to Rs 1,876 Cr; EBITDA grew 14% to Rs 308 Cr. PAT was Rs 133 Cr (after a Rs 42 Cr one-time provision). Ex-US Generics soared 36%. India branded and US Generics both rose 6%. PivyaTM launch planned.
No comments yet. Be the first to comment!